PubMed (GeneRIF) for id: 1002

Year	Number of Results
2004	2
2006	1
2009	2
2010	3
2011	1
2012	2
2014	1
2016	3
2017	1
2018	1
2019	2
2020	2
2021	1
2022	2
2023	2
2024	1

1

Cytosolic Cadherin 4 promotes angiogenesis and metastasis in papillary thyroid cancer by suppressing the ubiquitination/degradation of β-catenin.

Wu L, Xiao J, Yi D, Ding H, Wang R, Duan Z, Liu Z, Shi X, Shen M, Sang J. Wu L, et al. J Transl Med. 2024 Feb 24;22(1):201. doi: 10.1186/s12967-024-05012-1. J Transl Med. 2024. PMID: 38402159 Free PMC article.

2

Understanding the Role of CDH4 in Multiple System Atrophy Brain.

Isik FI, Katzeff JS, Fu Y, Kim WS. Isik FI, et al. J Parkinsons Dis. 2023;13(8):1303-1311. doi: 10.3233/JPD-230298. J Parkinsons Dis. 2023. PMID: 38143373 Free PMC article.

3

CDH4 inhibits ferroptosis in oral squamous cell carcinoma cells.

Xie J, Lan T, Zheng DL, Ding LC, Lu YG. Xie J, et al. BMC Oral Health. 2023 May 27;23(1):329. doi: 10.1186/s12903-023-03046-3. BMC Oral Health. 2023. PMID: 37237299 Free PMC article.

4

Alu Deletions in LAMA2 and CDH4 Genes Are Key Components of Polygenic Predictors of Longevity.

Erdman VV, Karimov DD, Tuktarova IA, Timasheva YR, Nasibullin TR, Korytina GF. Erdman VV, et al. Int J Mol Sci. 2022 Nov 4;23(21):13492. doi: 10.3390/ijms232113492. Int J Mol Sci. 2022. PMID: 36362280 Free PMC article.

5

Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression.

Martins-Lima C, Miranda-Gonçalves V, Lobo J, Constâncio V, Leite-Silva P, Guimarães-Teixeira C, Monteiro-Reis S, Sequeira JP, Cantante M, Gonçalves CS, Costa BM, Henrique R, Jerónimo C. Martins-Lima C, et al. Cell Oncol (Dordr). 2022 Feb;45(1):135-149. doi: 10.1007/s13402-021-00657-2. Epub 2022 Jan 22. Cell Oncol (Dordr). 2022. PMID: 35064910

6

Regulatory CDH4 Genetic Variants Associate With Risk to Develop Capecitabine-Induced Hand-Foot Syndrome.

Ruiz-Pinto S, Pita G, Martín M, Nuñez-Torres R, Cuadrado A, Shahbazi MN, Caronia D, Kojic A, Moreno LT, de la Torre-Montero JC, Lozano M, López-Fernández LA, Ribelles N, García-Saenz JA, Alba E, Milne RL, Losada A, Pérez-Moreno M, Benítez J, González-Neira A. Ruiz-Pinto S, et al. Clin Pharmacol Ther. 2021 Feb;109(2):462-470. doi: 10.1002/cpt.2013. Epub 2020 Sep 18. Clin Pharmacol Ther. 2021. PMID: 32757270

7

Expression and Prognostic Significance of Cadherin 4 (CDH4) in Renal Cell Carcinoma.

Zhou X, Huang H, Cui W, Wang Y, Luo W, Matskova L, Zhou X. Zhou X, et al. Med Sci Monit. 2020 Jun 8;26:e922836. doi: 10.12659/MSM.922836. Med Sci Monit. 2020. PMID: 32511216 Free PMC article.

8

Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics.

Ou-Yang F, Pan MR, Chang SJ, Wu CC, Fang SY, Li CL, Hou MF, Luo CW. Ou-Yang F, et al. Life Sci. 2019 Dec 1;238:116963. doi: 10.1016/j.lfs.2019.116963. Epub 2019 Oct 19. Life Sci. 2019. PMID: 31639396

9

Cdh4 Down-Regulation Impairs in Vivo Infiltration and Malignancy in Patients Derived Glioblastoma Cells.

Ceresa D, Alessandrini F, Bosio L, Marubbi D, Reverberi D, Malatesta P, Appolloni I. Ceresa D, et al. Int J Mol Sci. 2019 Aug 18;20(16):4028. doi: 10.3390/ijms20164028. Int J Mol Sci. 2019. PMID: 31426573 Free PMC article.

10

CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis.

Tang Q, Lu J, Zou C, Shao Y, Chen Y, Narala S, Fang H, Xu H, Wang J, Shen J, Khokha R. Tang Q, et al. Oncogene. 2018 Jul;37(27):3617-3630. doi: 10.1038/s41388-018-0231-2. Epub 2018 Apr 3. Oncogene. 2018. PMID: 29610525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

25 results

Results by year